ThreeVix-Seoul National University Graduate School of Public Health, MOU for Healthcare Big Data R&D and Commercialization

Park Jun-hyung, CEO of Three Vics (from the left), Won Seong-ho, Professor at Seoul National University Graduate School of Public Health.

[Asia Economy Reporter Kim Young-won] ThreeVix, a bio big data platform specialist company, announced on the 25th that it has signed a business agreement with Seoul National University Graduate School of Public Health for healthcare big data research and development and commercialization.

At the signing ceremony held at ThreeVix headquarters the previous day, both organizations agreed to jointly create a big data market in the healthcare sector based on ThreeVix's accumulated bio big data and artificial intelligence technology and various analysis and statistical platforms using medical data from Seoul National University Graduate School of Public Health.

Through this agreement, the two institutions plan to develop microbiome-based disease diagnosis and prediction, as well as food recommendation services, and will also proceed with overseas services including the United States and India next year.

Park Jun-hyung, CEO of ThreeVix, said, "With a differentiated strategy for disease diagnosis and prediction and prescription services platform that integrates personal health information, genomics, and microbiome data, we will become a leading company in the global healthcare business."

Professor Won Sung-ho of Seoul National University Graduate School of Public Health stated, "As the microbiome has been identified worldwide to affect various diseases such as atopy, obesity, diabetes, and dementia, we expect that this collaboration will commercialize meaningful microbiome-centered health management services and further contribute to increasing the national healthy lifespan."

This content was produced with the assistance of AI translation services.